Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000272

Director sold 28,000 shares at an average $74.02 ($2,072,578)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

WENDER JOSEPH H · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-30 Sale : show line 1 in the form 10b5-1 −2,484 $72.19 $179,320 89,551 I
2025-10-30 Sale : show line 2 in the form 10b5-1 −8,341 $73.16 $610,228 81,210 I
2025-10-30 Sale : show line 3 in the form 10b5-1 −5,975 $73.85 $441,254 75,235 I
2025-10-31 Sale : show line 4 in the form 10b5-1 −11,200 $75.16 $841,776 64,035 I
Open-market sales · 28,000 sh · avg $74.02 · $2,072,578
Loading xslF345X05/edgardoc.xml…